Vertex Pharmaceuticals Inc insider trading

VRTXfinancial statementsForm 4 filings on EDGAR306 transactions since Nov 1, 2024

From August 4, 2026 to November 1, 2026, 0 insiders at Vertex Pharmaceuticals Inc bought $0 of stock in the open market, and 0 sold $0. Officers and directors accounted for $0 of purchases and $0 of sales. The last reported transaction was an award by Brennan Daniel J. on October 20, 2026.

The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 22, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.

Stock price and insider activity

Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.

VRTX daily priceSplit-adjusted prices in US dollars

Bought $0Sold $0Aug 4, 2026 – Nov 1, 2026

Oct 30, 2026O $550.73 · H $563.80 · L $549.89 · C $558.88Bought $0 (0)Sold $0 (0)
$460$487$515$542$5702026-08-04: open $471.29, high $488.04, low $465.51, close $478.712026-08-05: open $487.52, high $491.95, low $479.02, close $484.832026-08-06: open $490.91, high $492.12, low $480.86, close $484.032026-08-07: open $487.11, high $497.40, low $482.10, close $496.072026-08-10: open $539.50, high $546.17, low $519.82, close $523.912026-08-11: open $525.02, high $532.23, low $522.01, close $529.652026-08-12: open $527.00, high $531.22, low $520.08, close $525.732026-08-13: open $528.68, high $529.00, low $515.74, close $516.442026-08-14: open $511.41, high $513.64, low $502.29, close $505.752026-08-17: open $503.87, high $517.84, low $502.53, close $515.552026-08-18: open $520.00, high $533.78, low $517.34, close $528.192026-08-19: open $537.47, high $553.69, low $532.55, close $552.062026-08-20: open $543.78, high $548.99, low $538.27, close $540.262026-08-21: open $545.10, high $555.32, low $540.70, close $548.052026-08-24: open $548.98, high $550.62, low $542.42, close $547.592026-08-25: open $545.53, high $555.69, low $543.75, close $552.852026-08-26: open $549.84, high $553.47, low $546.24, close $547.292026-08-27: open $540.08, high $550.83, low $540.08, close $547.552026-08-28: open $547.09, high $549.57, low $540.08, close $541.692026-08-31: open $535.38, high $546.84, low $532.23, close $544.522026-09-01: open $548.60, high $551.40, low $545.40, close $547.652026-09-02: open $552.42, high $558.36, low $549.07, close $556.752026-09-03: open $559.00, high $560.25, low $551.61, close $557.962026-09-04: open $549.50, high $556.99, low $544.48, close $546.122026-09-08: open $529.64, high $535.00, low $520.20, close $528.902026-09-09: open $524.00, high $528.17, low $520.08, close $521.122026-09-10: open $519.13, high $522.60, low $514.32, close $514.562026-09-11: open $522.10, high $522.10, low $511.81, close $515.442026-09-14: open $522.17, high $525.29, low $514.66, close $519.512026-09-15: open $519.94, high $519.94, low $511.00, close $514.632026-09-16: open $513.80, high $517.95, low $511.35, close $513.262026-09-17: open $518.35, high $519.07, low $510.20, close $516.342026-09-18: open $516.34, high $518.10, low $505.01, close $508.342026-09-21: open $506.85, high $514.10, low $501.01, close $510.722026-09-22: open $521.69, high $525.97, low $508.14, close $514.992026-09-23: open $515.60, high $525.43, low $509.56, close $516.342026-09-24: open $515.56, high $528.99, low $515.30, close $522.382026-09-25: open $522.55, high $527.69, low $518.92, close $526.192026-09-28: open $524.27, high $529.89, low $521.16, close $527.672026-09-29: open $522.22, high $529.46, low $519.25, close $526.732026-09-30: open $525.26, high $529.72, low $522.74, close $522.812026-10-01: open $522.39, high $523.52, low $505.27, close $506.742026-10-02: open $509.50, high $509.50, low $499.95, close $504.732026-10-05: open $504.78, high $506.01, low $496.15, close $503.502026-10-06: open $505.00, high $507.41, low $496.33, close $502.312026-10-07: open $504.08, high $511.51, low $503.94, close $505.642026-10-08: open $503.14, high $507.87, low $498.90, close $503.252026-10-09: open $502.11, high $514.90, low $502.06, close $510.082026-10-12: open $512.44, high $514.80, low $506.00, close $507.002026-10-13: open $507.55, high $508.57, low $484.08, close $485.222026-10-14: open $490.45, high $502.94, low $487.54, close $498.502026-10-15: open $514.91, high $517.68, low $507.21, close $508.752026-10-16: open $511.06, high $512.21, low $497.49, close $499.742026-10-19: open $500.00, high $505.83, low $499.50, close $501.952026-10-20: open $507.89, high $515.74, low $505.00, close $514.652026-10-21: open $512.79, high $528.57, low $510.48, close $524.522026-10-22: open $527.18, high $537.81, low $521.30, close $535.172026-10-23: open $531.66, high $533.08, low $522.91, close $523.932026-10-26: open $526.86, high $529.66, low $509.33, close $517.492026-10-27: open $514.84, high $521.43, low $509.21, close $521.032026-10-28: open $514.45, high $534.94, low $513.37, close $529.692026-10-29: open $536.46, high $546.61, low $534.01, close $540.002026-10-30: open $550.73, high $563.80, low $549.89, close $558.88Insider purchases / sales · USD$0No open-market purchases or sales in this period.Aug 4Aug 26Sep 17Oct 9Oct 30

purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.

Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.

Every transaction

306 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 20, 2026Brennan Daniel J.Directoraward795$503.47$400K795Oct 22, 2026
Sep 8, 2026van Grunsven JasperEVP, CP and NPPOaward8,682$0.00—8,682Sep 10, 2026
Aug 28, 2026Ambrose KristenSVP & Chief Accounting Officeraward5,000$0.00—11,624Sep 1, 2026
Aug 27, 2026Sachs Bruce IDirectorgift6,000$0.00—39,000Aug 31, 2026
Jul 21, 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.award8,251$0.00—53,572Jul 23, 2026
Jul 21, 2026Sachdev AmitEVP Chief Patient & Ext Af Offaward8,251$0.00—66,512Jul 23, 2026
Jul 2, 2026Tatsis OuraniaEVP, Chief Reg. & Quality Off.open-market sale10b5-11,500$524.99$787K45,321Jul 7, 2026
Jul 2, 2026McKechnie DuncanEVP, Chief Commercial Officeropen-market sale10b5-11,541$519.00$800K11,001Jul 7, 2026
Jul 1, 2026Liu JoyEVP and Chief Legal Officeropen-market sale10b5-1828$502.71$416K19,131Jul 6, 2026
Jun 26, 2026Bozic CarmenEVP and CMOopen-market sale10b5-1596$482.50$288K15,337Jun 30, 2026
Jun 18, 2026Bozic CarmenEVP and CMOopen-market sale10b5-11,020$462.17$471K15,933Jun 23, 2026
Jun 15, 2026Bozic CarmenEVP and CMOopen-market sale10b5-14,062$450.00$2M16,953Jun 17, 2026
Jun 5, 2026Bozic CarmenEVP and CMOopen-market sale10b5-11,745$450.00$785K21,015Jun 9, 2026
Jun 1, 2026Liu JoyEVP and Chief Legal Officeropen-market sale10b5-1828$439.91$364K19,959Jun 3, 2026
May 29, 2026Bozic CarmenEVP and CMOopen-market sale10b5-11,974$450.00$888K22,760Jun 2, 2026
May 15, 2026Bunnage Mark E.EVP, Chief Scientific Officeropen-market sale10b5-133$453.45$15K7,284May 19, 2026
May 15, 2026Bozic CarmenEVP and CMOopen-market sale10b5-11,354$453.45$614K24,734May 19, 2026
May 12, 2026Bozic CarmenEVP and CMOopen-market sale10b5-16,988$450.00$3M26,088May 14, 2026
May 4, 2026Bhatia Sangeeta N.Directoropen-market sale10b5-1318$423.73$135K4,924May 5, 2026
May 1, 2026Upadhyay SuketuDirectordisposition to issuer796——1,558May 5, 2026
May 1, 2026Thornberry NancyDirectoraward472$0.00—2,507May 5, 2026
May 1, 2026Thornberry NancyDirectordisposition to issuer398——2,109May 5, 2026
May 1, 2026Schneider JenniferDirectoraward472$0.00—2,190May 5, 2026
May 1, 2026Schneider JenniferDirectordisposition to issuer796——1,394May 5, 2026
May 1, 2026Mckenzie DianaDirectoraward943$0.00—3,174May 5, 2026
May 1, 2026Mckenzie DianaDirectordisposition to issuer796——2,378May 5, 2026
May 1, 2026Liu JoyEVP and Chief Legal Officeropen-market sale10b5-11,104$425.02$469K20,729May 5, 2026
May 1, 2026Garber Alan MDirectoraward472$0.00—7,344May 5, 2026
May 1, 2026Bhatia Sangeeta N.Directoraward943$0.00—5,242May 5, 2026
Apr 1, 2026Liu JoyEVP and Chief Legal Officeropen-market sale10b5-1978$449.17$439K21,833Apr 3, 2026
Mar 27, 2026Bozic CarmenEVP and CMOopen-market sale10b5-12,329$450.95$1M33,076Mar 31, 2026
Mar 13, 2026Bozic CarmenEVP and CMOopen-market sale10b5-12,329$481.79$1M35,405Mar 17, 2026
Mar 11, 2026McKechnie DuncanEVP, Chief Commercial Officeropen-market sale10b5-12,633$498.42$1M12,489Mar 13, 2026
Mar 4, 2026McKechnie DuncanEVP, Chief Commercial Officeropen-market sale10b5-12,437$475.30$1M15,122Mar 6, 2026
Mar 2, 2026Liu JoyEVP and Chief Legal Officeropen-market sale10b5-1892$495.96$442K22,811Mar 4, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-13,278$488.27$2M131,730Mar 3, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-12,510$487.13$1M135,008Mar 3, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-1240$482.84$116K137,518Mar 3, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-1120$481.50$58K137,758Mar 3, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-1400$479.75$192K137,878Mar 3, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-1460$489.32$225K131,270Mar 3, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-11,725$496.95$857K98,278Mar 3, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-15,995$496.16$3M100,003Mar 3, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-12,725$490.54$1M128,545Mar 3, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-1949$491.30$466K127,596Mar 3, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-12,520$493.29$1M125,076Mar 3, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-13,498$494.33$2M121,578Mar 3, 2026
Feb 27, 2026Kewalramani ReshmaCEO & President, Directoropen-market sale10b5-115,580$495.38$8M105,998Mar 3, 2026
Feb 27, 2026Bozic CarmenEVP and CMOopen-market sale10b5-12,329$480.31$1M37,734Mar 3, 2026
Feb 26, 2026Ambrose KristenSVP & Chief Accounting Officeropen-market sale10b5-1357$483.36$173K6,624Mar 2, 2026

Who the insiders are

Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.

InsiderRoleLast transactionKindShares heldBought, 12 monthsSold, 12 monthsSales under a plan
Leiden Jeffrey MExecutive Chairman, DirectorFeb 24, 2026tax withholding34,797—$61M (17)17 of 17
Sachdev AmitEVP Chief Patient & Ext Af OffJul 21, 2026award66,512—$28M (9)9 of 9
Kewalramani ReshmaCEO & President, DirectorFeb 27, 2026open-market sale131,730—$20M (13)13 of 13
Bozic CarmenEVP and CMOJun 26, 2026open-market sale15,337—$11M (10)10 of 10
Wagner Charles F JREVP, CO & FOFeb 24, 2026tax withholding47,042—$11M (3)3 of 3
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Jul 21, 2026award53,572—$7M (8)8 of 8
McKechnie DuncanEVP, Chief Commercial OfficerJul 2, 2026open-market sale11,001—$6M (5)5 of 5
Biller JonathanEVP and Chief Legal OfficerFeb 25, 2026open-market sale13,659—$4M (6)6 of 6
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 25, 2026open-market sale18,432—$4M (5)5 of 5
Bunnage Mark E.EVP, Chief Scientific OfficerMay 15, 2026open-market sale7,284—$3M (5)5 of 5
Liu JoyEVP and Chief Legal OfficerJul 1, 2026open-market sale19,131—$2M (5)5 of 5
Ambrose KristenSVP & Chief Accounting OfficerAug 28, 2026award11,624—$2M (5)5 of 5
Bhatia Sangeeta N.DirectorMay 4, 2026open-market sale4,924—$268K (2)2 of 2
Altshuler DavidEVP, Chief Scientific OfficerJan 22, 2026award31,149———
Arbuckle Stuart AEVP, COOJul 1, 2025tax withholding63,368———
Mckenzie DianaDirectorMay 1, 2026award3,174———
Sachs Bruce IDirectorAug 27, 2026gift39,000———
Upadhyay SuketuDirectorMay 1, 2026disposition to issuer1,558———
Thornberry NancyDirectorMay 1, 2026award2,507———
Schneider JenniferDirectorMay 1, 2026award2,190———
Garber Alan MDirectorMay 1, 2026award7,344———
Carney LloydDirectorNov 19, 2025gift6,315———
Brennan Daniel J.DirectorOct 20, 2026award795———
van Grunsven JasperEVP, CP and NPPOSep 8, 2026award8,682———

Questions

Are Vertex Pharmaceuticals Inc insiders buying or selling?

Over the twelve months to November 1, 2026, 13 insiders at Vertex Pharmaceuticals Inc sold $158M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $158M. Only open-market purchases and sales are counted.

Who sold the most Vertex Pharmaceuticals Inc stock in the last year?

Leiden Jeffrey M (Executive Chairman, Director) sold $61M in 17 open-market sales over the twelve months to November 1, 2026.

Do Vertex Pharmaceuticals Inc executives sell under 10b5-1 plans?

93 of the 93 open-market sales in the last twelve months (100%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.

What counts as insider buying here?

Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.

More on Vertex Pharmaceuticals Inc

From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.